Advertisement

Topics

Shionogi-ViiV Healthcare LLC Company Profile

17:59 EDT 23rd September 2017 | BioPortfolio

'572 is the lead compound in Shionogi-ViiV Healthcare LLC. It is currently the only once-daily, unboosted integrase inhibitor in Phase IIb clinical development. Shionogi-ViiV Healthcare LLC is also developing second-generation integrase inhibitors, including S/GSK1265744, currently in Phase II development.


News Articles [948 Associated News Articles listed on BioPortfolio]

ViiV Healthcare seeks EMA, FDA approvals for two-drug regimen to treat HIV-1 infection

ViiV Healthcare, a joint venture of GlaxoSmithKline (GSK), Pfizer, and Shionogi, is seeking approval from the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) for the HIV ...

GlaxoSmithKline buys $130M for HIV Priority Voucher

GSK and ViiV Healthcare, a global specialist HIV company majority-owned by GSK, with Pfizer and Shionogi as shareholders, announced regulatory submissions to the EMA and FDA for a single-tablet, two-d...

GSK Reports EU & US Submissions For First HIV Maintenance Regimen

LONDON (dpa-AFX) - GSK and ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, announced regulatory submissions to the ...

ViiV reaches another milestone

On July 24, 2017, ViiV Healthcare announced positive results from 96-week data obtained from a Phase IIb, open-label study (LATTE-2) investigating the safety and efficacy of a two-drug, long-acting in...

ViiV reaches another milestone in the development of a long-acting HIV regimen

On July 24, 2017, ViiV Healthcare announced positive results from 96-week data obtained from a Phase IIb, open-label study (LATTE-2) investigating the safety and efficacy of a two-drug, long-acting in...

ViiV seeks EU, US approval for HIV-1 infection 2-drug combo

A marketing application has been filed by ViiV Healthcare to the FDA and European Commission for its single-tablet regimen of -More- 

GlaxoSmithKline makes submissions for key HIV single-tablet treatment to both the EMA and the US FDA

GlaxoSmithKline plc (LON:GSK) and ViiV Healthcare have made regulatory submissions to both the European Medicines Agency and the US Food and Drug Administration for use of a single-tablet, two-drug re...

EU and US Submissions for Single Tablet Combining Dolutegravir and Rilpivirine Priority Review Voucher Submitted in US with Anticipated Target Action Date of 6 Months

London, UK 01 June 2017 – GSK and ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced regulatory submissi...

Drugs and Medications [467 Associated Drugs and Medications listed on BioPortfolio]

Prenate elite [Shionogi Pharma, Inc.]

PRENATE ELITE Tablets Rx

Prenate essential [Sciele Pharma, Inc.]

Prenate Essential™ Rx prenatal vitamin & DHA

Retrovir [ViiV Healthcare Company]

These highlights do not include all the information needed to use RETROVIR safely and effectively. See full prescribing information for RETROVIR.RETROVIR (zidovudine) Tablets, Capsules, and SyrupIniti...

Selzentry [ViiV Healthcare Company]

These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) TabletsInitial U.S. Approval:...

Selzentry [ViiV Healthcare Company]

These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) TabletsInitial U.S. Approval: ...

Clinical Trials [785 Associated Clinical Trials listed on BioPortfolio]

Prospective Non-Interventional Observational Study of Use of TRIUMEQ and Corresponding Monitoring Measures in Clinical Practice in Germany

TRIUMPH is a prospective, non-interventional observational study on the use of the fixdose combination TRIUMEQ (Dolutegravir/Abacavir/Lamivudine) and the respective monitoring measures in ...

My Life, My Healthcare

This study is designed to answer the following questions: "Is the My Life, My Healthcare Discussion Aid feasible for use in primary care? Does it positively impact patient and healthcare t...

Asymptomatic Flu Project

Although clinical presentation of influenza is often symptomatic, asymptomatic cases also occur. The knowledge of the incidence of asymptomatic influenza among healthcare workers is very i...

Ubiquitous Healthcare Service With Multifactorial Intervention in Diabetes Care

Recently, we generated a new multidisciplinary ubiquitous healthcare system by upgrading our clinical decision supporting system (CDSS) rule engine, and integrating a physical activity-mon...

Implementation of Medical Weight Management by Telemedicine

As the prevalence and associated healthcare costs of obesity continue to increase, the need for obesity treatments that contribute to weight loss maintenance are needed. Through the functi...

Companies [1724 Associated Companies listed on BioPortfolio]

Shionogi-ViiV Healthcare LLC

'572 is the lead compound in Shionogi-ViiV Healthcare LLC. It is currently the only once-daily, unboosted integrase inhibitor in Phase IIb clinical development. Shionogi-ViiV Healthcare LLC is also de...

Shionogi & Co., Ltd.

Headquartered in Osaka, Japan, Shionogi & Co., Ltd. is a major research-driven pharmaceutical company dedicated to placing the highest value on patients. Shionogi’s Research ...

ViiV Healthcare

ViiV Healthcare is a global specialist HIV company established by GlaxoSmithKline (NYSE: GSK) and Pfizer (NYSE: PFE) to deliver advances in treatment and care for people living with HIV. Our aim is t...

Shionogi Pharma, Inc.

Headquartered in Osaka, Japan, Shionogi & Co., Ltd. is a major research-driven pharmaceutical company dedicated to placing the highest value on patients. Shionogi’s Research ...

Shionogi Inc.

Shionogi Inc. is a US-based company of Shionogi & Co., Ltd. Headquartered in Osaka, Japan, Shionogi & Co., Ltd. is a major research-driven pharmaceutical company dedicated to plac...

More Information about "Shionogi-ViiV Healthcare LLC" on BioPortfolio

We have published hundreds of Shionogi-ViiV Healthcare LLC news stories on BioPortfolio along with dozens of Shionogi-ViiV Healthcare LLC Clinical Trials and PubMed Articles about Shionogi-ViiV Healthcare LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Shionogi-ViiV Healthcare LLC Companies in our database. You can also find out about relevant Shionogi-ViiV Healthcare LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record